logo
Select company
Select metric
$ -38.77MNet Cash Flow - Change in Cash & Cash Equivalents
VS
Market
20
Sector
18
Industry
19
History
30
$ 5.62Close
$ 3.81 - $ 9.02 52-Week Range
Ticker Information

Ticker

DTIL

Company Name

PRECISION BIOSCIENCES INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

PRECISION BIOSCIENCES INC - Net Cash Flow - Change in Cash & Cash Equivalents Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

DTIL - CF - Chg. Cash Historical data
DateNet Cash Flow - Change in Cash & Cash Equivalents
6/30/2025$ -38.77M
3/31/2025$ -37.98M
12/31/2024$ -8.21M
9/30/2024$ -903K
6/30/2024$ -14.22M
3/31/2024$ -20.37M
12/31/2023$ -72.9M
9/30/2023$ -89.82M
6/30/2023$ -46.34M
3/31/2023$ 41.91M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PRECISION BIOSCIENCES INC's latest trailing twelve months (TTM) CF - Chg. Cash stands at $ -102.12M.
  • Over the past 5 years, PRECISION BIOSCIENCES INC's average CF - Chg. Cash has been $ -12.69M.
  • The median CF - Chg. Cash for PRECISION BIOSCIENCES INC during this period was $ -11.22M
  • PRECISION BIOSCIENCES INC reached its highest CF - Chg. Cash over the past 5 years at $ 56.32M.
  • The lowest CF - Chg. Cash recorded by PRECISION BIOSCIENCES INC in the same timeframe $ -102.12M

PRECISION BIOSCIENCES INC's CF - Chg. Cash vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Chg. Cash Benchmarks
CompanyCF - Chg. Cash
ADVM : ADVERUM BIOTECHNOLOGIES INC $ -84.9MRANI : RANI THERAPEUTICS HOLDINGS INC $ 5.7MPLUR : PLURI INC $ -475KIGC : IGC PHARMA INC $ -1.37MCLSD : CLEARSIDE BIOMEDICAL INC $ -8.86MRNXT : RENOVORX INC $ 572KLSTA : LISATA THERAPEUTICS INC $ -11.46MSONN : SONNET BIOTHERAPEUTICS HOLDINGS INC $ -3.23MCOEP : COEPTIS THERAPEUTICS HOLDINGS INC $ 441.65KSER : SERINA THERAPEUTICS INC $ -73K

Definition of Net Cash Flow - Change in Cash & Cash Equivalents

[Cash Flow Statement] Represents the amount of increase (decrease) in cash and cash equivalents. Includes cash from operations [NCFO], investing [NCFI] and financing [NCFF], adjusted for the effect of exchange rate changes on cash [NCFX]

DTIL - Net Cash Flow - Change in Cash & Cash Equivalents, Last 5 years

$ -102.12M

Minimum

Sep 30, 2020

$ 56.32M

Maximum

Sep 30, 2021

$ -12.69M

Average

$ -11.22M

Median

CF - Chg. Cash Benchmark Analysis

The chart above depicts the distribution of CF - Chg. Cash for companies in the Total Stock Market. The average CF - Chg. Cash of the companies is $ 1.18M with a standard deviation of $ 45.08M.
The following table provides additional summary stats:
CF - Chg. Cash in the Market:
filtered constituents3.34K
min$ -137M
max$ 138.09M
average$ 1.18M
median$ 116.12K
std$ 45.08M